Search

everythinglearnresearchcommunity

for

Search:↓

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

The method accurately measures hair growth with minimal risk and is better than other techniques.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The Tyrolean Iceman had mostly Anatolian farmer ancestry and traits like darker skin and a risk for certain health issues.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

Oral retinoids are effective for treating severe skin disorders but have reversible side effects and risks for pregnant women.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Hair loss risk is influenced by multiple genes.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Ethosomes improve drug delivery through the skin but may have side effects like irritation.

The environment around melanocyte stem cells is key for hair regeneration and color, with certain injuries affecting hair color and potential treatments for pigmentation disorders.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Fiber implantation for pattern baldness was largely unsuccessful with many complications and is not recommended.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Men with hair loss have higher BMI, waist size, blood pressure, and are linked to smoking and inactivity.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

WNT10A and EBF1 interaction affects hair growth in male-pattern baldness.

Oral isotretinoin was recommended for a 21-year-old woman with severe acne.